- All sections
- A - Human necessities
- A01N - Preservation of bodies of humans or animals or plants or parts thereof biocides, e.g. as disinfectants, as pesticides or as herbicides pest repellants or attractantsplant growth regulators
- A01N 33/02 - AminesQuaternary ammonium compounds
Patent holdings for IPC class A01N 33/02
Total number of patents in this class: 388
10-year publication summary
|
19
|
14
|
17
|
10
|
12
|
13
|
16
|
3
|
9
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Teva Pharmaceutical Industries Ltd. | 646 |
8 |
| Teva Pharmaceuticals USA, Inc. | 636 |
7 |
| BASF SE | 21308 |
6 |
| Kimberly-clark Worldwide, Inc. | 5305 |
5 |
| Dow AgroSciences LLC | 1185 |
5 |
| SK Biopharmaceuticals Co., Ltd. | 277 |
5 |
| Ecolab USA Inc. | 5803 |
4 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1354 |
4 |
| Legacy Pharma Inc. SEZC | 48 |
4 |
| Glaxosmithkline LLC | 527 |
3 |
| The Trustees of Columbia University in the City of New York | 3648 |
3 |
| AgroFresh Inc | 144 |
3 |
| Alaven Pharmaceutical LLC | 17 |
3 |
| Aptalis Pharma Canada ULC | 19 |
3 |
| Instraction GmbH | 48 |
3 |
| Kemira Oyj | 1257 |
3 |
| Nestlé Skin Health S.A. | 37 |
3 |
| NeuroDerm, Ltd. | 143 |
3 |
| Rhodia Operations | 1491 |
3 |
| SOLENIS TECHNOLOGIES, L.P., Solenis International, L.P., a Delaware limited partnership, DBA Solenis Technologies, L.P. | 223 |
3 |
| Other owners | 307 |